Takeda Unites San Diego Biotech R&D Center

Sarah de Crescenzo of Xconomy reports that Takeda, a global Japanese biopharmaceutical company, first made a U.S. acquisition in 2005 (Syrrx). 14 years and several acquisitions later Takeda is consolidating its’ San Diego affiliates into one custom built R&D...

Pin It on Pinterest